The promise of patient-derived xenografts: the best laid plans of mice and men
about
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsOne mouse, one patient paradigm: New avatars of personalized cancer therapyCurrent status and evolution of preclinical drug development models of epithelial ovarian cancerCombined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.From bench to bedside: lessons learned in translating preclinical studies in cancer drug developmentDiscovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical ModelingGefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastomaMultimodal imaging of a humanized orthotopic model of hepatocellular carcinoma in immunodeficient mice.Ex vivo tumor culture systems for functional drug testing and therapy response predictionPhenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient miceIntegrated next-generation sequencing and avatar mouse models for personalized cancer treatment.Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotypeMouse Tumor Biology (MTB): a database of mouse models for human cancerDiscovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cellsComprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine.Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumorsCorrelation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patientsHuman lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivityProteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerPilot studies for personalized cancer medicine: focusing on the patient for treatment selection.Establishment of Patient-derived Xenografts in Mice.Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts.Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell Carcinoma.Implications of intratumour heterogeneity for treatment stratification.Cancer and comparative imaging.Translational research in oncology--10 years of progress and future prospects.Modeling of Patient-Derived Xenografts in Colorectal Cancer.Loss of SLCO1B3 drives taxane resistance in prostate cancerPreclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).Tumor evolution: Linear, branching, neutral or punctuated?Nanoparticles for combination drug therapy.Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.Tumor heterogeneity and personalized cancer medicine: are we being outnumbered?A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia.LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer.
P2860
Q26772895-D68DDDA6-DC6B-4F16-88E6-52A9819BFF12Q27023342-7DFCBAFB-35BC-4C17-A4E0-5450F8F61598Q27028117-F3995B6F-7ACB-400B-84B6-3AEE6A4BD740Q27853216-0526E569-8390-4AB8-AF2E-990EB79D20A7Q28533949-5B31F499-7797-44B3-B389-56DEE55E945EQ28547862-E7FBE52E-02A1-4FE8-9037-25C19A22B8AAQ30541574-78F8C32E-08FD-421D-884B-E5F457B8D791Q30822612-6CBDCD16-EBED-4FF7-97F4-DE79D3AE0ECFQ33827247-451D70B9-5FBF-4345-A12E-0F33A2A64400Q35053317-DDED04DD-E661-4B24-A9CF-557770855016Q35067532-572C7B09-8CAC-4C2F-8A59-BB2A14D9325AQ35147858-7ECE4D0E-29CC-40AD-9117-D951D01F923EQ35254961-875757B2-A6BB-480A-B923-1C59233663D5Q35747414-8B795E8B-B472-469B-A96B-6D8A3D6995C6Q35822579-00C683CB-CB09-443F-BCAF-26542BADF1B8Q35832158-8C9FA008-9507-4050-82CF-9950AAC6677BQ36140720-58C7CE8E-6487-4566-B87C-BC1BF0FD548CQ36634788-5F179649-8907-4F03-9434-49487071689FQ36693061-242B329F-912E-4DA9-97DB-957AB55D6B93Q36886874-EB03F2D3-704B-45B1-9C80-949B9911D3B7Q37007341-99318948-2C6C-49EC-BA07-7E35C3BC1D4EQ37301452-12B21C40-C251-4998-84D7-C89980B86FD1Q37626404-FCF822F6-330E-4297-B3C8-668C55886CD5Q37636793-02E5A59D-A412-4EE5-8847-9DDB85ED200FQ37708733-C01F0D0E-FC16-4822-A68E-C407D33F98B5Q37712156-530C70DA-6F3E-496C-BCD6-44D1BE9B2773Q38151633-AC86B33A-F820-4D86-839B-835304D6862AQ38220808-AE5ACDAD-837D-485C-9F07-15881C32170DQ38257126-CC97C8FF-1F00-4F91-BE1B-98A5D4168ECAQ38705019-723CCB8F-DB72-4403-8DF0-40299DF3432AQ38751260-A6CD3864-4FAC-4F6B-A625-6B4F2DB59097Q38834695-8DE146C3-3FF2-48C9-A0B1-EDB85040F691Q39007635-03258CD6-26CF-4627-A694-DCB888747BADQ39055298-02664531-0C42-441C-BB60-B79D35503F6BQ39131399-0012830A-6B93-43AF-A07B-7248ECF9A838Q39246718-731EC34F-1DE7-435D-916E-09C2C08E1971Q41658087-0B620F95-93D9-4215-9BB1-24195DA4BA8AQ42041565-39D7DBF8-0EB1-4065-AB23-C040151E6F10Q42315779-8A3575A3-632A-4AD2-B667-A0C4CB10C319Q42576914-31BD25F7-142F-449B-80CF-F09B7022E0BB
P2860
The promise of patient-derived xenografts: the best laid plans of mice and men
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The promise of patient-derived xenografts: the best laid plans of mice and men
@ast
The promise of patient-derived xenografts: the best laid plans of mice and men
@en
The promise of patient-derived xenografts: the best laid plans of mice and men
@nl
type
label
The promise of patient-derived xenografts: the best laid plans of mice and men
@ast
The promise of patient-derived xenografts: the best laid plans of mice and men
@en
The promise of patient-derived xenografts: the best laid plans of mice and men
@nl
prefLabel
The promise of patient-derived xenografts: the best laid plans of mice and men
@ast
The promise of patient-derived xenografts: the best laid plans of mice and men
@en
The promise of patient-derived xenografts: the best laid plans of mice and men
@nl
P2860
P1476
The promise of patient-derived xenografts: the best laid plans of mice and men
@en
P2093
Robert Lemos
Scott Kopetz
P2860
P304
P356
10.1158/1078-0432.CCR-12-2408
P407
P50
P577
2012-08-21T00:00:00Z